Page 246 - 2021_06-Haematologica-web

1748
Letters to the Editor
USA; 3Department of Internal Medicine, Virginia Commonwealth University Medical Center, Richmond, VA, British Columbia, Canada and 4Department of Medicine; Jesse Brown VA Medical Center, Chicago, IL, USA
Correspondence: SANTOSH L. SARAF - ssaraf@uic.edu doi:10.3324/haematol.2020.267872
Received: July 23, 2020.
Accepted: October 12, 2020.
Pre-published: October 29, 2020.
Disclosures: no conflicts of interest to disclose.
Contributions: AS and SLS designed and performed research, ana- lyzed the data, and wrote the paper; JH, RR, MG, FH, FN, REM, and VRG designed and performed research and wrote the paper.
Funding: the project described was supported by the National Institutes of Health through grants R03 HL-146788, and R01 HL- 153161 (SLS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
References
1. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(4 Suppl):S512-521.
2. Battersby AJ, Knox-Macaulay HH, Carrol ED. Susceptibility to inva- sive bacterial infections in children with sickle cell disease. Pediatr Blood Cancer. 2010;55(3):401-406.
3. Darbari DS, Wang Z, Kwak M, et al. Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study. PLoS One. 2013;8(11):e79923.
4. Quinn CT, Rogers ZR, McCavit TL, Buchanan GR. Improved sur- vival of children and adolescents with sickle cell disease. Blood. 2010;
115(17):3447-3452.
5. Rogovik AL, Friedman JN, Persaud J, Goldman RD. Bacterial blood
cultures in children with sickle cell disease. Am J Emerg Med. 2010;
28(4):511-514.
6. CDC. Antibiotic resistance threats in the United States. www.cdc-
gov/DrugResistance/Biggest-Threatshtml. 2019.
7. Daw NC, Wilimas JA, Wang WC, et al. Nasopharyngeal carriage of
penicillin-resistant Streptococcus pneumoniae in children with sickle
cell disease. Pediatrics. 1997;99(4):e7.
8.Chulamokha L, Scholand SJ, Riggio JM, Ballas SK, Horn D,
DeSimone JA. Bloodstream infections in hospitalized adults with sickle cell disease: a retrospective analysis. Am J Hematol. 2006; 81(10):723-728.
9. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an interna- tional expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-281.
10. Ho DE, Imai K, King G, Stuart EA. MatchIt: nonparametric prepro- cessing for parametric causal inference. J Stat Softw. 2011;42(8):1-28. 11. Woudt SHS, de Greeff SC, Schoffelen AF, Vlek ALM, Bonten MJM. Infectious Diseases Surveillance Information System-Antimicrobial Resistance Study Group. Antibiotic resistance and the risk of recur-
rent bacteremia. Clin Infect Dis. 2018;66(11):1651-1657.
12. Centers for Disease Control and Prevention. Prevention of pneumo- coccal disease: recommendations of the Advisory Committee on
Immunization Practices (ACIP). 1997 Apr 4;46(RR-8):1-24.
13. Burnham JP, Rojek RP, Kollef MH. Catheter removal and outcomes of multidrug-resistant central-line-associated bloodstream infection.
Medicine. 2018;97(42):e12782.
14. Chaftari AM, Hachem R, Jiang Y, et al. Changing epidemiology of
catheter-related bloodstream infections in cancer patients. Infect
Control Hosp Epidemiol. 2018;39(6):727-729.
15. van Lunzen J, Altfeld M. Sex differences in infectious diseases-com-
mon but neglected. J Infect Dis. 2014;209(Suppl 3):S79-80.
haematologica | 2021; 106(6)